Ch
Redefining Care for Incurable Diseases Through Next-Gen Delivery Tech
we are doing
Gene To The Future
2018

Founded In

Become China's leading high-tech biopharmaceutical companyand build a global multi-field drug research and development platform

The founder team includes top scientists in the field of gene therapy, industrial experts with a background in international pharmaceutical companies, and Anping toxicology experts with preclinical drug evaluation experience.



The advisory team includes authoritative experts in gene therapy, clinicians from top-tier tertiary hospitals, and executives of listed pharmaceutical companies.

Gene Editing
-BD-VLP Platform

Gene Editing Transient Delivery Technology---BDgene realizes the safe and efficient delivery of CRISPR and other gene editing tools through the leading viroid BDmRNA delivery technology.

Gene Addition
-BDlenti Platform

Leading lentiviral design and process platform---BDgene's advanced lentiviral vector delivery technology effectively improves the virus production and the infection efficiency of hematopoietic stem cells.

01

/ 02

Gene Addition BDlenti

Next one

Gene Aditing-BD-VLP Platform

Next one

Share With You

All News
logo
info@bdgene.cn

Email

Building 10, No.55 Bixi Road, Minhang District, Shanghai,China

ADD

open

close